Literature DB >> 15221799

A CD36 nonsense mutation associated with insulin resistance and familial type 2 diabetes.

Frédéric Leprêtre1, Francis Vasseur, Martine Vaxillaire, Philipp E Scherer, Saira Ali, Kenneth Linton, Timothy Aitman, Philippe Froguel.   

Abstract

Mutations in CD36 / fatty acid translocase (FAT) gene are responsible for insulin resistance in the rat but contribution to human Type 2 diabetes is unknown. A nominal evidence for linkage of familial T2D at the CD36 locus led us to identify a rare nonsense mutation c.1079T>G (p.L360X) in one Caucasian pedigree presenting with autosomal dominant diabetes. Adiponectin levels, as marker of insulin sensitivity, were found to be significantly lower in the p.L360X variant carriers compared to homozygous for wild type CD36. Furthermore, expression studies of the truncated protein showed a defective binding of acetylated-LDL. Thus, our findings suggest a possible role for CD36 in the pathogenesis of T2D associated with reduced insulin sensitivity. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15221799     DOI: 10.1002/humu.9256

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  16 in total

1.  Molecular basis of human CD36 gene mutations.

Authors:  Monika Ewa Rać; Krzysztof Safranow; Wojciech Poncyljusz
Journal:  Mol Med       Date:  2007 May-Jun       Impact factor: 6.354

2.  Variants in the CD36 gene associate with the metabolic syndrome and high-density lipoprotein cholesterol.

Authors:  Latisha Love-Gregory; Richard Sherva; Lingwei Sun; Jon Wasson; Timothy Schappe; Alessandro Doria; D C Rao; Steven C Hunt; Samuel Klein; Rosalind J Neuman; M Alan Permutt; Nada A Abumrad
Journal:  Hum Mol Genet       Date:  2008-02-27       Impact factor: 6.150

Review 3.  CD36: implications in cardiovascular disease.

Authors:  Maria Febbraio; Roy L Silverstein
Journal:  Int J Biochem Cell Biol       Date:  2007-03-23       Impact factor: 5.085

4.  Association between rs1761667 polymorphism of CD36 gene and risk of coronary atherosclerosis in Egyptian population.

Authors:  Ahmed Boghdady; Usama Ahmed Arafa; Eman A Sabet; Eman Salama; Ahmed El Sharawy; Mahmoud I Elbadry
Journal:  Cardiovasc Diagn Ther       Date:  2016-04

5.  Parkin reinvents itself to regulate fatty acid metabolism by tagging CD36.

Authors:  Nada A Abumrad; Darren J Moore
Journal:  J Clin Invest       Date:  2011-08-25       Impact factor: 14.808

6.  Common CD36 SNPs reduce protein expression and may contribute to a protective atherogenic profile.

Authors:  Latisha Love-Gregory; Richard Sherva; Timothy Schappe; Jian-Shen Qi; Jennifer McCrea; Samuel Klein; Margery A Connelly; Nada A Abumrad
Journal:  Hum Mol Genet       Date:  2010-10-08       Impact factor: 6.150

7.  Associations between CD36 gene polymorphisms, fat tolerance and oral fat preference in a young-adult population.

Authors:  A F Jayewardene; Y Mavros; D P Hancock; T Gwinn; K B Rooney
Journal:  Eur J Clin Nutr       Date:  2016-07-27       Impact factor: 4.016

8.  Absence of CD36 protects against atherosclerosis in ApoE knock-out mice with no additional protection provided by absence of scavenger receptor A I/II.

Authors:  Sai Kuchibhotla; Difernando Vanegas; David J Kennedy; Ella Guy; George Nimako; Richard E Morton; Maria Febbraio
Journal:  Cardiovasc Res       Date:  2007-12-07       Impact factor: 10.787

9.  Cd36, a class B scavenger receptor, functions as a monomer to bind acetylated and oxidized low-density lipoproteins.

Authors:  Catherine A Martin; Emma Longman; Carol Wooding; Sarah J Hoosdally; Saira Ali; Timothy J Aitman; Daniel A P Gutmann; Paul S Freemont; Bernadette Byrne; Kenneth J Linton
Journal:  Protein Sci       Date:  2007-09-28       Impact factor: 6.725

10.  Protein-mediated Fatty Acid Uptake in the Heart.

Authors:  Adrian Chabowski; Jan Górski; Jan F C Glatz; Joost J F P Luiken; Arend Bonen
Journal:  Curr Cardiol Rev       Date:  2008-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.